Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 469681 - 469700 out of 483109 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (A16AX08) teduglutide (adm: P) | GATTEX 5MG INJ, 30 VIAL KIT | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (A16AX09) glycerol phenylbutyrate (adm: O) | RAVICTI 1.1GM/ML | 25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Urea Cycle Disorders, Inborn | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX09) glycerol phenylbutyrate (adm: O) | RAVICTI 1.1GM/ML | 25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Urea Cycle Disorders, Inborn | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX10) eliglustat (adm: O) | CERDELGA 84MG CAP,UD | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gaucher Disease | GenzymeCorporation |
| USA | (A16AX10) eliglustat (adm: O) | CERDELGA 84MG CAP,UD | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gaucher Disease | GenzymeCorporation |
| USA | (A16AX12) trientine (adm: O, expressed as trientine) | CUVRIOR 300MG TAB | 72 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | OrphalanLimited |
| USA | (A16AX13) uridine triacetate | VISTOGARD | 4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BTGInternational,Inc. |
| USA | (A16AX13) uridine triacetate | VISTOGARD | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BTGInternational,Inc. |
| USA | (A16AX13) uridine triacetate | VISTOGARD | 4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BTGInternational,Inc. |
| USA | (A16AX13) uridine triacetate | VISTOGARD | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BTGInternational,Inc. |
| USA | (A16AX13) uridine triacetate | XURIDEN | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BTGInternational,Inc. |
| USA | (A16AX13) uridine triacetate | XURIDEN | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BTGInternational,Inc. |
| USA | (A16AX14) migalastat (adm: O) | GALAFOLD 123 MG CAPSULE | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | AmicusTherapeuticsUS,LLC |
| USA | (A16AX14) migalastat (adm: O) | GALAFOLD 123 MG CAPSULE | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | AmicusTherapeuticsUS,LLC |
| USA | (A16AX15) telotristat (adm: O) | XERMELO 250MG TAB | 4X21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoid Tumor;Neuroendocrine Tumors | TerSeraTherapuetics,LLC |
| USA | (A16AX15) telotristat (adm: O) | XERMELO 250MG TAB | 4X21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoid Tumor;Neuroendocrine Tumors | TerSeraTherapuetics,LLC |
| USA | (A16AX16) givosiran | GIVLAARI 189MG/ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Porphyrias, Hepatic | AlnylamPharmaceuticals,Inc. |
| USA | (A16AX16) givosiran | GIVLAARI 189MG/ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Porphyrias, Hepatic | AlnylamPharmaceuticals,Inc. |
| USA | (A16AX18) lumasiran | OXLUMO 94.5MG/0.5ML VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hyperoxaluria, Primary | AlnylamPharmaceuticals,Inc. |
| USA | (A16AX18) lumasiran | OXLUMO 94.5MG/0.5ML VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hyperoxaluria, Primary | AlnylamPharmaceuticals,Inc. |
Pages
